ExpreS2ion Biotechnologies and the Jenner Institute, University of Oxford Enter a Licensing Agreement

Product News   Oct 15, 2012

 
ExpreS2ion Biotechnologies and the Jenner Institute, University of Oxford Enter a Licensing Agreement
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Lonza Expands Service Offerings for Early Phase Biopharmaceutical Drug Development

Product News

Protein Sequence Variant Analysis de-risks clinical candidates. Site-Specific Conjugation Vectors for GS Xceed® System support expression of second-generation antibody drug conjugates. Developability assessment expanded to include microbial-derived recombinant proteins.

READ MORE

Lonza Launches XS™ Pichia 2.0 Expression and Manufacturing Platform for Development of Next Generation Therapeutics

Product News

New system designed to provide high product titers up to 6 g/L, with a fermentation strategy that results in drastically-reduced fermentation times. Platform is available under license for use in customer’s facility or as a service offering.

READ MORE

HVEM Products for Immuno-Oncology Research

Product News

AMSBIO's new range of HVEM products of particular interest to those studying TNFR family members.

READ MORE

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE